← back to search

Kristof Chwalisż

Grand Rapids Community College · US
Area of research
Reproductive Medicine · Obstetrics and Gynecology
Research interest
Research interests include Endometriosis Research and Treatment, Uterine Myomas and Treatments, Reproductive System and Pregnancy, and Estrogen and related hormone effects.
h-index
50
citations
7,999
works
200
NIH funding
primary concept
email

Recent publications

Clinical development of the GnRH agonist leuprolide acetate depot.
2023cited by 6position: contributordoi
Clinical development of the oral gonadotropin-releasing hormone antagonist elagolix.
2023cited by 5position: contributordoi
Long-Term Outcomes of Elagolix in Women With Endometriosis
Obstetrics and Gynecology 2018cited by 130position: lastdoi
Elagolix Alone or With Add-Back Therapy in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas
Obstetrics and Gynecology 2018cited by 71position: middledoi
Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist
New England Journal of Medicine 2017cited by 487position: lastdoi
World Endometriosis Research Foundation Endometriosis Phenome and biobanking harmonization project: II. Clinical and covariate phenotype data collection in endometriosis research
Fertility and Sterility 2014cited by 231position: middledoi
World Endometriosis Research Foundation Endometriosis Phenome and Biobanking Harmonization Project: III. Fluid biospecimen collection, processing, and storage in endometriosis research
Fertility and Sterility 2014cited by 226position: middledoi
World Endometriosis Research Foundation Endometriosis Phenome and Biobanking Harmonisation Project: IV. Tissue collection, processing, and storage in endometriosis research
Fertility and Sterility 2014cited by 160position: middledoi
Elagolix, an Oral GnRH Antagonist for Endometriosis-Associated Pain: A Randomized Controlled Study
Journal of Endometriosis and Pelvic Pain Disorders 2013cited by 63position: lastdoi
Efficacy and Safety of Leuprolide Acetate 3-Month Depot 11.25 Milligrams or 30 Milligrams for the Treatment of Central Precocious Puberty
The Journal of Clinical Endocrinology & Metabolism 2012cited by 70position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Bruce R. Carr · University of Florida4 papers (2013–2018)Nelson B. Watts · Mercy Health3 papers (2017–2018)David F. Archer · Emory University3 papers (2017–2018)W. Paul Dmowski · Creighton University3 papers (2013–2018)Michael P. Diamond · University of Manchester3 papers (2017–2018)W. Rachel Duan · AbbVie (United States)3 papers (2017–2018)Linda C. Giudice · University of California, San Francisco3 papers (2013–2018)James A. Simon · George Washington University3 papers (2017–2018)Ahmed M. Soliman · Kafrelsheikh University2 papers (2018–2018)James W. Thomas · Vanderbilt University2 papers (2017–2018)Neil P. Johnson · University of Adelaide2 papers (2017–2018) · 2 papers (2017–2018) · 2 papers (2023–2023)Maurício Simões Abrão · Universidade de São Paulo2 papers (2017–2018)Nicholas Leyland · The Society of Obstetricians and Gynaecologists of Canada2 papers (2017–2018)John C. Gallagher · Creighton University2 papers (2017–2018)Bruce A. Lessey · Atrium Health Wake Forest Baptist2 papers (2017–2018)Brittany Schwefel · AbbVie (United States)2 papers (2017–2018)Hugh S. Taylor · Yale University2 papers (2017–2018)Juki Ng · AbbVie (United States)2 papers (2017–2018)